Bluejay Diagnostics completes enrollment in sepsis IL-6 study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/24/2026

1. INTC
2. DECK
3. AMD
4. INFY
5. RNG
6. UNP
7. DGX
8. ACI
9. ROL
10. URI

Go back to Bluejay Diagnostics completes enrollment in sepsis IL-6 study
(NASDAQ: BJDX) Delayed: 1.08 -0.06 (5.26%)
Previous Close $1.14    52 Week High $ 
Open $1.13    52 Week Low $ 
Day High $1.13    P/E N/A 
Day Low $1.07    EPS $ 
Volume 114,358